| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Finance > Don't Let A Broker Take You For A Ride |
|
Just Other Articles - Don't Let A Broker Take You For A Ride
If you have recently applied for a loan and have paid an arrangement fee to your broker According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product , but have not taken up the offer, then you are entitled to a full refund of this money ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , less a fee of ?5.00. The Office of Fair Trading (OFT) recently alerted consumers to lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. he fact that if they are not found a suitable loan within six months and don't take up here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe any loan offered - for whatever reason - the broker can keep only ?5 of the arrangement d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro fee. On it’s website the OFT that: “The Consumer Credit Act limits a credit broker's c ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc harges to ?5 if, following an introduction to a lender, an agreement is not signed with easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi n six months. If more than that has already been paid, brokers must refund the excess o nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n request.” According to the OFT, it has been found that some brokers are targeting di and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ advantaged consumers. The broker will get their fee up front (approximately ?50) and on ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ly afterwards does the consumer find that the prospective credit provider will only len ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a d them amounts less than they require or that loans are only available with a guarantor dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod Understandably, the consumer may wish to reject the loan offered and many do but are cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin not aware that they are entitled for a full refund of the arrangement fee, less a fiver tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen People having difficulty obtaining a refund should contact their local trading standa t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel rds service. Under section 155 of the Consumer Credit Act 1974 - which applies to a num ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust er of types of agreement including mortgages and consumer loans of ?25,000 or less. - a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products credit broker may charge no more than ?5 for its services if the consumer does not ent . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r into an agreement within six months of an introduction to a lender. If the broker has elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip already charged more than ?5, the excess must be refunded to the consumer upon request tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why Selling a Business is Different from Selling Anything Else Step by Step Guide to Internet Success Part 7-Identifying the Needs of Your Niche Market Search Engine Marketing - An Effective Tool for Marketing
|